Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Cancer Investigation|January 1, 1990
Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) studyJ N Winter, P S Ritch, S T Rosen, et al.The Annals of Thoracic Surgery|August 1, 1993
Brain protection via cerebral retrograde perfusion during aortic arch aneurysm repairH J Safi, H W Brien, J N Winter, et al.Blood|November 24, 1999
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensityL I Gordon, M Young, E Weller, et al.Bone Marrow Transplantation|November 20, 2002
Lack of caregivers limits use of outpatient hematopoietic stem cell transplant programP Frey, T Stinson, A Siston, et al.Cancer Research|June 1, 1986
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomasK D Bauer, D E Merkel, J N Winter, et al.Bone Marrow Transplantation|May 16, 2003
Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?M Y Ali, Y Oyama, J Monreal, et al.Blood|December 15, 1990
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemiaC M Rubin, R A Larson, J Anastasi, et al.Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphomaJ F DiPersio, M W Schuster, C N Abboud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiencyS H McDunn, J N Winter, D Variakojis, et al.Pageof 6